Moreover, BRCA in SLE patients presents a different histologic type and receptor status than that in patients without SLE, with a population-based case–control study reporting that SLE patients have a decreased risk of estrogen receptor (ER)-negative cancers [6]. Here, ESR1 is linked to systemic lupus erythematosus.